{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:23:49Z","timestamp":1782959029253,"version":"3.54.5"},"reference-count":83,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCA PLBIO 11527"],"award-info":[{"award-number":["INCA PLBIO 11527"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"University of Strasbourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bbadis.2024.167471","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T18:12:23Z","timestamp":1724350343000},"page":"167471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hypoxia-driven heterogeneous expression of \u03b15 integrin in glioblastoma stem cells is linked to HIF-2\u03b1"],"prefix":"10.1016","volume":"1870","author":[{"given":"M\u00e9lissa","family":"Mess\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Foppolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Herold-Mende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Idbaih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Etienne-Selloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam K.","family":"Tambar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Laquerriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Entz-Werle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Reita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Dontenwill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2024.167471_bb0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2024.167471_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-023-04348-w","article-title":"Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis","volume":"164","author":"Ballo","year":"2023","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0015","first-page":"1602","article-title":"Gene expression-based classification of malignant gliomas correlates better with survival than histological classification","volume":"63","author":"Nutt","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167471_bb0020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Cancer Genome Atlas Research Network","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2024.167471_bb0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0045","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0050","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2024.167471_bb0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41467-019-09853-z","article-title":"Stem cell-associated heterogeneity in glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment","volume":"10","author":"Dirkse","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2024.167471_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/neuonc\/noaa259","article-title":"The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions","volume":"23","author":"Mitchell","year":"2021","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2024.167471_bb0065","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41374-021-00695-2","article-title":"Phenotyping clonal populations of glioma stem cell reveals a high degree of plasticity in response to changes of microenvironment","volume":"102","author":"Innes","year":"2022","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2024.167471_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/carcin\/bgu243","article-title":"Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target","volume":"36","author":"Jackson","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2024.167471_bb0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00401-013-1196-4","article-title":"Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes","volume":"127","author":"Stieber","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0085","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/annonc\/mdx217","article-title":"Structural and functional intratumor heterogeneities in glioblastoma: a spacetime odyssey at single-cell level","volume":"28","author":"Idbaih","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.canlet.2016.04.007","article-title":"Glioma cell dispersion is driven by \u03b15 integrin-mediated cell-matrix and cell-cell interactions","volume":"376","author":"Blandin","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2024.167471_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","article-title":"Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance","volume":"25","author":"Seguin","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/cancers5010027","article-title":"Integrin \u03b15\u03b21, the fibronectin receptor, as a pertinent therapeutic target in solid tumors","volume":"5","author":"Schaffner","year":"2013","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2024.167471_bb0105","doi-asserted-by":"crossref","first-page":"86947","DOI":"10.18632\/oncotarget.20372","article-title":"Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update","volume":"8","author":"Malric","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2024.167471_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.stem.2010.02.018","article-title":"Integrin alpha 6 regulates glioblastoma stem cells","volume":"6","author":"Lathia","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.celrep.2013.11.043","article-title":"High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor","volume":"6","author":"Lathia","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2024.167471_bb0120","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/bjc.2013.218","article-title":"Integrin \u03b13 is overexpressed in glioma stem-like cells and promotes invasion","volume":"108","author":"Nakada","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbadis.2024.167471_bb0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.stem.2017.04.009","article-title":"Integrin \u03b17 is a functional marker and potential therapeutic target in glioblastoma","volume":"21","author":"Haas","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0130","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1038\/onc.2017.248","article-title":"Glioblastoma stem cells exploit the \u03b1v\u03b28 integrin-TGF\u03b21 signaling axis to drive tumor initiation and progression","volume":"36","author":"Guerrero","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2024.167471_bb0135","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/1541-7786.MCR-18-0386","article-title":"Inhibiting integrin \u03b28 to differentiate and Radiosensitize glioblastoma-initiating cells","volume":"17","author":"Malric","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167471_bb0140","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1158\/0008-5472.CAN-11-4199","article-title":"Integrin \u03b15\u03b21 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma","volume":"72","author":"Janouskova","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167471_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/biom1010003","article-title":"Comparative studies of vertebrate Beta integrin genes and proteins: ancient genes in vertebrate evolution","volume":"1","author":"Holmes","year":"2011","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbadis.2024.167471_bb0150","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/ph14090882","article-title":"Expression analysis of \u03b15 integrin subunit reveals its upregulation as a negative prognostic biomarker for glioblastoma","volume":"14","author":"Etienne-Selloum","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bbadis.2024.167471_bb0155","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbadis.2024.167471_bb0160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.bbadis.2024.167471_bb0165","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ijc.26415","article-title":"Involvement of the TGF\u03b2 pathway in the regulation of \u03b15 \u03b21 integrins by caveolin-1 in human glioblastoma","volume":"131","author":"Cosset","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2024.167471_bb0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.stem.2011.04.013","article-title":"Deadly teamwork: neural cancer stem cells and the tumor microenvironment","volume":"8","author":"Lathia","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0175","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1158\/0008-5472.CAN-15-0708","article-title":"PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A\/EPAS1 and vascularization in neuroblastoma","volume":"75","author":"Mohlin","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167471_bb0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccr.2006.08.026","article-title":"Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype","volume":"10","author":"Holmquist-Mengelbier","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0185","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/path.2304","article-title":"High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche","volume":"214","author":"Pietras","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0190","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1158\/1078-0432.CCR-11-0682","article-title":"Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1\u03b1 in advanced solid tumors","volume":"17","author":"Kummar","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167471_bb0195","doi-asserted-by":"crossref","first-page":"71597","DOI":"10.18632\/oncotarget.16500","article-title":"Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1\u03b1 axis inhibition","volume":"8","author":"Nguyen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2024.167471_bb0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2119\/molmed.2011.00120","article-title":"In vivo topoisomerase I inhibition attenuates the expression of hypoxia-inducible factor 1\u03b1 target genes and decreases tumor angiogenesis","volume":"18","author":"Gu\u00e9rin","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2024.167471_bb0205","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1021\/acs.jmedchem.9b00719","article-title":"3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a hypoxia-inducible factor 2\u03b1 (HIF-2\u03b1) inhibitor for the treatment of clear cell renal cell carcinoma","volume":"62","author":"Xu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2024.167471_bb0210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nchembio.1185","article-title":"Allosteric inhibition of hypoxia inducible factor-2 with small molecules","volume":"9","author":"Scheuermann","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0215","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1021\/acs.jmedchem.5b00529","article-title":"Isoform-selective and Stereoselective inhibition of hypoxia inducible Factor-2","volume":"58","author":"Scheuermann","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2024.167471_bb0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/cancers14020369","article-title":"Temozolomide-acquired resistance is associated with modulation of the integrin repertoire in glioblastoma, impact of \u03b15\u03b21 integrin","volume":"14","author":"Sani","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2024.167471_bb0225","doi-asserted-by":"crossref","first-page":"62194","DOI":"10.18632\/oncotarget.11552","article-title":"Expression\/activation of \u03b15\u03b21 integrin is linked to the \u03b2-catenin signaling pathway to drive migration in glioma cells","volume":"7","author":"Renner","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2024.167471_bb0230","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.drudis.2021.09.021","article-title":"The aryl hydrocarbon receptor: a diagnostic and therapeutic target in glioma","volume":"27","author":"Lim","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbadis.2024.167471_bb0235","doi-asserted-by":"crossref","first-page":"11342","DOI":"10.1074\/jbc.RA119.008882","article-title":"The aryl hydrocarbon receptor is a tumor suppressor-like gene in glioblastoma","volume":"294","author":"Jin","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2024.167471_bb0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-2797(02)00065-0","article-title":"The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation","volume":"141","author":"Pollenz","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2024.167471_bb0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2024.167471_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.863850","article-title":"Targeting integrins for cancer therapy - disappointments and opportunities","volume":"10","author":"Bergonzini","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2024.167471_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.962481","article-title":"Pathophysiological roles of integrins in gliomas from the perspective of glioma stem cells","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0265","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3390\/cancers13081795","article-title":"A systematic review of glioblastoma-targeted therapies in phases II, III, IV clinical trials","volume":"13","author":"Cruz Da Silva","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2024.167471_bb0270","doi-asserted-by":"crossref","first-page":"13329","DOI":"10.2147\/OTT.S273803","article-title":"The roles of integrin \u03b15\u03b21 in human Cancer","volume":"13","author":"Hou","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bbadis.2024.167471_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24228","article-title":"ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma","volume":"36","author":"Zhou","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bbadis.2024.167471_bb0280","first-page":"4048","article-title":"Integrin \u03b1-5 as a potential biomarker of head and neck squamous cell carcinoma","volume":"18","author":"Zou","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2024.167471_bb0285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.humpath.2015.09.029","article-title":"Integrin \u03b15 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma","volume":"48","author":"Xie","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.canlet.2021.11.008","article-title":"Integrin \u03b15 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma","volume":"526","author":"Miyamoto","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2024.167471_bb0295","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.7150\/ijbs.72367","article-title":"The interactions between integrin \u03b15\u03b21 of liver cancer cells and fibronectin of fibroblasts promote tumor growth and angiogenesis","volume":"18","author":"Peng","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2024.167471_bb0300","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41388-020-01603-6","article-title":"Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions","volume":"40","author":"Pantano","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2024.167471_bb0305","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax2770","article-title":"ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer","volume":"5","author":"Kuninty","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbadis.2024.167471_bb0310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12032-022-01902-w","article-title":"ITGA5 inhibition in pancreatic stellate cells re-educates the in vitro tumor-stromal crosstalk","volume":"40","author":"Wang","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0315","article-title":"ITGA5 is a novel oncogenic biomarker and correlates with tumor immune microenvironment in gliomas","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0320","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2010.12.362","article-title":"A phase II, single-arm study of the anti-\u03b15\u03b21 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer","volume":"121","author":"Bell-McGuinn","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0325","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","article-title":"Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells","volume":"15","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0330","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7150\/thno.41692","article-title":"Glioma stem cells and their roles within the hypoxic tumor microenvironment","volume":"11","author":"Boyd","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbadis.2024.167471_bb0335","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.ajpath.2012.01.040","article-title":"The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma","volume":"180","author":"Cooper","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0340","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/1541-7786.MCR-16-0338","article-title":"Hypoxia selectively enhances integrin \u03b15\u03b21 receptor expression in breast Cancer to promote metastasis","volume":"15","author":"Ju","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167471_bb0345","doi-asserted-by":"crossref","first-page":"21306","DOI":"10.1073\/pnas.0906432106","article-title":"Human cancers converge at the HIF-2alpha oncogenic axis","volume":"106","author":"Franovic","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbadis.2024.167471_bb0350","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/brain\/awq042","article-title":"A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2\u03b1","volume":"133","author":"Seidel","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2024.167471_bb0355","doi-asserted-by":"crossref","first-page":"v361","DOI":"10.1093\/annonc\/mdz249.010","article-title":"911PD - a first-in-human phase I\/II trial of the oral HIF-2a inhibitor PT2977 in patients with advanced RCC","volume":"30","author":"Jonasch","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0360","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-022-01354-5","article-title":"Belzutifan (MK-6482): biology and clinical development in solid tumors","author":"Choi","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bbadis.2024.167471_bb0365","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s40265-021-01606-x","article-title":"Belzutifan: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bbadis.2024.167471_bb0370","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7150\/ijbs.86317","article-title":"Hypoxia-driven TNS4 fosters HNSCC tumorigenesis by stabilizing integrin \u03b15\u03b21 complex and triggering FAK-mediated Akt and TGF\u03b2 signaling pathways","volume":"20","author":"Zhao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2024.167471_bb0375","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2023.01.008","article-title":"Nitric oxide promotes cell-matrix adhesion of endothelial progenitor cells under hypoxia condition via ITGA5 CpG promoter demethylation","volume":"644","author":"Behera","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2024.167471_bb0380","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201756","article-title":"Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma","volume":"6","author":"Lafleur","year":"2023","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.bbadis.2024.167471_bb0385","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41593-019-0370-y","article-title":"Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39","volume":"22","author":"Takenaka","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2024.167471_bb0390","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","article-title":"IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression","volume":"182","author":"Sadik","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2024.167471_bb0395","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.7150\/thno.60679","article-title":"Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma","volume":"11","author":"Panitz","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbadis.2024.167471_bb0400","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coi.2020.12.003","article-title":"Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies","volume":"70","author":"Leclerc","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0405","article-title":"Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties","volume":"5","author":"Mavingire","year":"2022","journal-title":"Precis Clin. Med."},{"key":"10.1016\/j.bbadis.2024.167471_bb0410","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bcp.2008.09.031","article-title":"The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism","volume":"77","author":"Kung","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167471_bb0415","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2016.03.025","article-title":"AhR ligand Aminoflavone inhibits \u03b16-integrin expression and breast cancer sphere-initiating capacity","volume":"376","author":"Brantley","year":"2016","journal-title":"Cancer Lett."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924004642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924004642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:47:35Z","timestamp":1778770055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924004642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":83,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0925443924004642"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167471","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia-driven heterogeneous expression of \u03b15 integrin in glioblastoma stem cells is linked to HIF-2\u03b1","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167471"}}